Literature DB >> 18274523

Simple protocols for NMR analysis of the enantiomeric purity of chiral diols.

Andrew M Kelly1, Yolanda Pérez-Fuertes, John S Fossey, Sonia Lozano Yeste, Steven D Bull, Tony D James.   

Abstract

A three-component chiral derivatization protocol for determining the enantiopurity of chiral diols by (1)H NMR spectroscopic analysis is described here. The present approach involves the derivatization of 1,2- 1,3- and 1,4-diols with 2-formylphenylboronic acid and enantiopure alpha-methylbenzylamine. This method affords a mixture of diastereoisomeric iminoboronate esters whose ratio can be determined by integration of well-resolved diastereotopic resonances in their (1)H NMR spectra, thus enabling the determination of the enantiopurity of the parent diol. The protocol as described takes less than 90 min to complete.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18274523     DOI: 10.1038/nprot.2007.523

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  4 in total

1.  The Bull-James assembly as a chiral auxiliary and shift reagent in kinetic resolution of alkyne amines by the CuAAC reaction.

Authors:  William D G Brittain; Brette M Chapin; Wenlei Zhai; Vincent M Lynch; Benjamin R Buckley; Eric V Anslyn; John S Fossey
Journal:  Org Biomol Chem       Date:  2016-11-22       Impact factor: 3.876

2.  A chiral phosphazane reagent strategy for the determination of enantiomeric excess of amines.

Authors:  Andrew J Peel; Alexandros Terzopoulos; Rajesh B Jethwa; Dipanjana Choudhury; Hao-Che Niu; Andrew D Bond; Jonathan Slaughter; Dominic S Wright
Journal:  Chem Sci       Date:  2022-04-25       Impact factor: 9.969

Review 3.  Self and directed assembly: people and molecules.

Authors:  Tony D James
Journal:  Beilstein J Org Chem       Date:  2016-03-01       Impact factor: 2.883

4.  NMR analysis of the enantiomeric purity of chiral diols by a new chiral boron agent.

Authors:  Xuebo Zhang; Jing Xu; Zhaofeng Sun; Guangling Bian; Ling Song
Journal:  RSC Adv       Date:  2022-02-08       Impact factor: 3.361

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.